100 Clinical Results associated with CHINOIN Pharmaceutical Co.
Login to view more data
0 Patents (Medical) associated with CHINOIN Pharmaceutical Co.
Login to view more data
6
Literatures (Medical) associated with CHINOIN Pharmaceutical Co.
15 Jun 1998·Acta Crystallographica Section C Crystal Structure Communications
Irbesartan Crystal Form B
Author: Rodger, Charles A. ; Bauer, Michel ; Caron, Antoine ; Simon, Kalman ; Bocskei, Zsolt ; Rao, Renee
Irbesartan (2-butyl-3-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diaaspiro[4.4]non-1-en-4-one, C25H28-N6O), a highly selective angiotensin II receptor (AT1) antagonist was found to exist in two distinct crystal forms (A and B).This paper describes the crystal structure of irbesartan form B.Crystallog. data are given.
15 Aug 1996·Acta Crystallographica Section C Crystal Structure Communications
Trimethylsilyl N-(4-bromophenyl)carbamate, C10H14BrNO2Si, and trimethylsilyl N-tert-butyl-N-phenylcarbamate, C14H23NO2Si, are both important silylating agent.The structures of both mols. are dominated by a plane containing a remarkably large number of atoms.The planes are organized by delocalization around the carbamate moiety.A quasi-pentacoordination of the Si atom in both compounds is also described.Crystallog. data and at. coordinates are given.
15 May 1996·Acta Crystallographica Section C Crystal Structure Communications
A Side-Chain Substituted Cholesterol Analog
Author: Szendi, Zsuzsa ; Sweet, Frederick ; Bocskei, Zsolt
The crystal structure of (20R,22RS)-27-norcholest-5-en-3β,20,22-triol 3,22-diacetate, C30H48O5, is reported.Crystallog. data and at. coordinates are given.
100 Deals associated with CHINOIN Pharmaceutical Co.
Login to view more data
100 Translational Medicine associated with CHINOIN Pharmaceutical Co.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.